Skip to content

Efficacy and safety of AYUSH SR in Premenstrual Syndrome

Efficacy and safety of AYUSH SR in the management of Premenstrual Syndrome a Randomized Double Blind Placebo Controlled Study - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071600
Enrollment
80
Registered
2024-07-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N943- Premenstrual tension syndrome

Interventions

None listed

Sponsors

Central Council For Research In Ayurvedic Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Female participants of reproductive age group (18-40) with regular menstrual cycle (between 21 and 35 days) having moderate symptoms as per PSST tool(Premenstrual Symptoms Screening Tool). 2.Symptoms should occur during the luteal phase. 3.Willing to participate in the study

Exclusion criteria

Exclusion criteria: 1.Patients diagnosed with Uterine fibroids , polyps and congenital uterine anomalies. 2.Diagnosed patients with diabetes mellitus, poorly controlled Hypertension(Blood pressure more than 160/100 mm of Hg) or hormonal disorders. 3.Patients with concurrent hepatic disorderdefined as aspartate amino transferase and/or alanine amino transferase greater than 2 times the upper normal limit or renal disorders defined as serum Creatinine greater than the upper limit of laboratory value) 4.Patients who are undergoing any hormonal treatment or using contraceptive pills. 5.Psychiatric disorders and malignant conditions 6.Pregnant/lactating females. 7.Patients who have completed participation in any other clinical trial during the past six (06) months. 8.Any other condition that the Investigator thinks may jeopardize the study

Design outcomes

Primary

MeasureTime frame
Changes in the Premenstrual Symptoms Screening tool PSST tool.Timepoint: Baseline, Visit 2 Visit 3 Visit 4 Visit 5

Secondary

MeasureTime frame
Changes in values of LFT and RFTTimepoint: Baseline, Visit 4;Changes in values of Serum Progesterone, SerumEstradiol ,FSH and LHTimepoint: Baseline, Visit 4;Improvement in Psychological General Well-Being using PGWBI ScoreTimepoint: Baseline, Visit 2 Visit 3 Visit 4 Visit 5

Countries

India

Contacts

Public ContactDr Anumol K

Regional Ayurveda Research Institute Vijayawada CCRAS Ministry of AYUSH

dranumolk@gmail.com9497264955

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026